Back to search

Article

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

2021-01-14

Abstract excerpt

SARS-CoV-2 entry into host cells is orchestrated by the spike (S) glycoprotein that contains an immunodominant receptor-binding domain (RBD) targeted by the largest fraction of neutralizing antibodies (Abs) in COVID-19 patient plasma. Little is known about neutralizing Abs binding to epitopes outside the RBD and their contribution to protection. Here, we describe 41 human monoclonal Abs (mAbs) derived from memory...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c26d1b09-b1bb-5fab-a2d6-f59c96b524f0
DOI
10.1101/2021.01.14.426475
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2DOI 10.1101/2021.01.14.426475
Select a neighboring publication to make it the new centre.